Catalent Biologics Content
-
Transitioning From Vial To Prefilled Syringe
Understand how formulation development for a prefilled syringe affects manufacturing, driving the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.
-
Accelerate Biopharmaceutical Development With Novel Analytical Techniques
Get insights on how using an Octet-based Fc receptor panel may help developers achieve a faster assessment of monoclonal antibody functionality, well before the final molecule is selected.
-
Get Your Biologic To Clinic And Market Faster
Catalent Biologics is your one integrated partner with the expertise to get your biologics to market faster. We have the passion to help you accelerate, simplify, and de-risk your biologics from development and manufacturing to fill/finish, to clinical supply, and commercial launch.
-
Enable Oral Delivery Of Synthetic Oligosaccharides
Due to their poor oral bioavailability, oligosaccharides are formulated as solutions or suspensions and delivered by intravenous (IV) or subcutaneous injection. This case study demonstrates how one technology significantly increases oral bioavailability of a synthetic oligosaccharide, thus enabling oral conversion.
-
The Faster Path To Self-Administration
Explore how to quickly transition your product from pre-filled syringe to auto-injector with a partner who can anticipate equipment and process needs.
-
Biopharma 4.0 – Digital Transformation In The Biopharma Industry
Biopharma 4.0 advances include the widespread automation of business processes within a company, comprehensive data integration, and interoperability between manufacturing and operations.
-
The GPEx Suite Of Technologies For Cell Line Development
Biopharma products in development continue to increase in complexity, which poses a challenge for pharmaceutical companies looking to improve speed and efficiency of biologic development.
-
Achieving A Successful Drug Product Technology Transfer
Get insights on key considerations for a successful process transfer for manufacturing a drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent.
-
Parallel Approaches, Diverse Partnerships Combat COVID-19
Get a behind-the-scenes look at efforts to develop a COVID-19 vaccine, as it happened, and the collaborative mindset that brought it here as quickly and safely as possible.
-
Generating A Fully Processed Antibody
Discover cell-line development and process scale-up for an antibody program where the antibody requires additional processing by a site-specific enzyme for correct functionality.